Recent Posts by our contributor, joseph mansour
Mon, 06/11/2012 - 2:57pm
In an unprecedented breakthrough in breast cancer research, the FDA approved a new drug that should improve on the treatment of one of the most deadly forms of breast cancer to date, HER2-positive.
Wed, 08/08/2012 - 3:00pm
Pfizer and Johnson & Johnson stated on Monday that they have ended the development of an intravenous drug that was supposed to aid patients with Alzheimer’s disease, according to Bloomberg.com.